Meningococcal polysaccharide vaccination of military recruits in Israel: preliminary assessment of vaccine effect.
Meningococcal disease in the Israel Defense Force is caused mainly by serogroups C and Y. Immunization of recruits with quadrivalent polysaccharide vaccine was introduced in November 1994. The person-time incidence rate dropped from 1.33 cases per 100,000 person-years for the preceding decade to 0 for the 32 months following immunization (p = 0.025).
Mimouni
D
D
Medical Corps, Israel Defense Force, Ramat-Hasharon, Israel.
Gdalevich
M
M
Mandel
Y
Y
Haim
M
M
Ashkenazi
I
I
Shemer
J
J
Block
C
C
D000293:Adolescent; D000328:Adult; D001428:Bacterial Vaccines / Q000276:immunology*; D005260:Female; D006801:Humans; D007557:Israel / Q000453:epidemiology; D008297:Male; D008589:Meningococcal Infections / Q000453:epidemiology / Q000517:prevention & control*; D008875:Middle Aged; D008889:Military Personnel; D009345:Neisseria meningitidis / Q000145:classification / Q000276:immunology*; D011135:Polysaccharides, Bacterial / Q000276:immunology; D012703:Serotyping; D014611:Vaccination
D001428:Bacterial Vaccines; D011135:Polysaccharides, Bacterial